Growth Metrics

Harmony Biosciences Holdings (HRMY) Income towards Parent Company: 2019-2025

Historic Income towards Parent Company for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Sep 2025 value amounting to $50.9 million.

  • Harmony Biosciences Holdings' Income towards Parent Company rose 10.35% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year increase of 44.38%. This contributed to the annual value of $117.5 million for FY2024, which is 1.78% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Income towards Parent Company stood at $50.9 million, which was up 27.88% from $39.8 million recorded in Q2 2025.
  • Harmony Biosciences Holdings' Income towards Parent Company's 5-year high stood at $87.9 million during Q3 2022, with a 5-year trough of -$9.6 million in Q3 2021.
  • Its 3-year average for Income towards Parent Company is $33.6 million, with a median of $38.3 million in 2024.
  • The largest annual percentage gain for Harmony Biosciences Holdings' Income towards Parent Company in the last 5 years was 59,688.89% (2021), contrasted with its biggest fall of 603.93% (2021).
  • Quarterly analysis of 5 years shows Harmony Biosciences Holdings' Income towards Parent Company stood at $19.1 million in 2021, then soared by 154.53% to $48.5 million in 2022, then slumped by 72.81% to $13.2 million in 2023, then skyrocketed by 62.84% to $21.5 million in 2024, then rose by 10.35% to $50.9 million in 2025.
  • Its Income towards Parent Company stands at $50.9 million for Q3 2025, versus $39.8 million for Q2 2025 and $45.6 million for Q1 2025.